Published in Medical Letter on the CDC and FDA, April 6th, 2008
The 46,000 square foot single-occupant specialized use facility was specifically designed and constructed for development and GMP manufacturing and distribution of point-of-care (POC) medical diagnostic test kits. Response Biomedical designs, develops, manufactures and distributes rapid POC tests for use with its portable RAMP(R) platform for clinical and environmental applications. The new facility should allow manufacturing scale-up from approximately...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.